Edition:
India

NeuroMetrix Inc (NURO.OQ)

NURO.OQ on NASDAQ Stock Exchange Capital Market

1.42USD
1:30am IST
Change (% chg)

$0.01 (+0.71%)
Prev Close
$1.41
Open
$1.40
Day's High
$1.44
Day's Low
$1.39
Volume
3,777
Avg. Vol
84,111
52-wk High
$4.56
52-wk Low
$1.20

Latest Key Developments (Source: Significant Developments)

NeuroMetrix Q1 Revenue Rose 15 Percent To $4.9 Million
Thursday, 19 Apr 2018 

April 19 (Reuters) - NeuroMetrix Inc ::NEUROMETRIX REPORTS Q1 2018 FINANCIAL RESULTS.Q1 REVENUE ROSE 15 PERCENT TO $4.9 MILLION.QTRLY NET INCOME WAS $1.2 MILLION IN COMPARISON WITH A NET LOSS OF $3.2 MILLION IN Q1 2017.  Full Article

Neurometrix Reports Preliminary 2017 Financial Highlights
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Neurometrix Inc ::NEUROMETRIX REPORTS PRELIMINARY 2017 FINANCIAL HIGHLIGHTS.NEUROMETRIX INC - PRELIMINARY GAAP REVENUE FOR Q4 OF 2017 IS ESTIMATED AT APPROXIMATELY $4.9 MILLION IN COMPARISON WITH $3.7 MILLION IN Q4 2016.  Full Article

Neurometrix- in talks for partnerships for quell wearable pain relief technology
Tuesday, 16 Aug 2016 

Neurometrix Inc : Neurometrix commentary on strategic and business partnerships for quell wearable pain relief technology . Says is currently engaged in discussions around several types of partnerships including an e-commerce collaboration in US market .Also currently engaged in discussions around several types of partnerships for licensing, distribution rights to European, Asian markets, research and development.  Full Article

Neurometrix reports Q2 loss per share of $5.37
Thursday, 21 Jul 2016 

Neurometrix Inc : Neurometrix reports q2 2016 financial results and highlights . Neurometrix reports q2 2016 financial results and highlights . Q2 loss per share $5.37 . Q2 revenue rose 116 percent to $2.65 million .Q2 earnings per share view $-0.93, revenue view $2.7 million -- Thomson Reuters I/B/E/S.  Full Article

Neurometrix says expands DPNCheck commercialization in Mexico
Wednesday, 13 Jul 2016 

Neurometrix : Neurometrix expands DPNCheck commercialization in Mexico .Commercial expansion of DPNCheck in Mexico following receipt of a purchase order from one of Mexico's six major government healthcare institutions.  Full Article

Neurometrix says $21.3 mln private placement of preferred stock,warrants
Friday, 3 Jun 2016 

Neurometrix Inc: Neurometrix announces $21.3 million at the market private placement of preferred stock and warrants . Says private placement of 21,300 shares of series C convertible preferred stock at a price of $1,000 per share .Expected that about $13.8 million of proceeds of offering will be used to redeem 13,800 shares of series c convertible preferred stock.  Full Article

BRIEF-NeuroMetrix Q1 Revenue Rose 15 Percent To $4.9 Million

* QTRLY NET INCOME WAS $1.2 MILLION IN COMPARISON WITH A NET LOSS OF $3.2 MILLION IN Q1 2017 Source text for Eikon: Further company coverage: